Notify me when J. Goldman & Co LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| DMYY | dMY Squared Technology Group, Inc. | Common Stock | 6.4% | $1,845,000 | -$922,500 | 150,000 | -33% | J. Goldman & Co LP | 30 Sep 2025 |
| PCAP | ProCap Acquisition Corp | Common Stock | 6.2% | $16,299,820 | 1,595,550 | J. Goldman & Co LP | 30 Sep 2025 | ||
| ONCH | 1RT Acquisition Corp. | Common Stock | 6.2% | $11,158,594 | 1,078,125 | J. Goldman & Co LP | 30 Sep 2025 | ||
| EGRX | EAGLE PHARMACEUTICALS, INC. | Common Stock | 5.1% | $1,934,613 | 667,108 | J. Goldman & Co LP | 30 Jun 2025 | ||
| NLOP | Net Lease Office Properties | REIT | 4.6% | $21,101,638 | 672,455 | J. Goldman & Co LP | 31 Dec 2023 | ||
| GRDN | Guardian Pharmacy Services, Inc. | Common Stock | 2.9% | $17,229,438 | -$2,471,496 | 656,860 | -13% | J. Goldman & Co LP | 30 Sep 2025 |
| ZIMV | ZimVie Inc. | Common Stock | 0% | $0 | -$27,015,392 | 0 | -100% | J. Goldman & Co LP | 30 Sep 2025 |
| MCGAU | Yorkville Acquisition Corp. | Unit | 0% | $0 | -$8,848,000 | 0 | -100% | J. Goldman & Co LP | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|